Schedule 13G ownership disclosure

MERSANA THERAPEUTICS INC

Security class unavailable · CUSIP: 59045L106

Event date: 2019-12-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,483,903
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-075212
Form type
SC 13G
Filer
Mersana Therapeutics, Inc.
CIK
CIK 1442836
Filed
Dec 23, 2019
Reporting period
Dec 13, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub